Anatomic Pathology Market Size, Prominent Players, and Key Figures Reviewed in Latest Research Report | MarketsandMarkets™

Anatomic Pathology Market Size, Prominent Players, and Key Figures Reviewed in Latest Research Report | MarketsandMarkets™

May 04
21:33 2023
Anatomic Pathology Market Size, Prominent Players, and Key Figures Reviewed in Latest Research Report | MarketsandMarkets™
F. Hoffmann-La Roche AG (Switzerland) was the leading player in the anatomic pathology market. The company has a wide range of products in the consumables segment. Strong business operations across all key regions, coupled with a strong brand image, make the firm a leading player in this market.
Browse 491 market data Tables and 45 Figures spread through 343 Pages and in-depth TOC on “Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region – Global Forecasts to 2026

Global Anatomic Pathology Market Overview

The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. Anatomic Pathology is a medical field dedicated to examining tissues and cells for disease diagnosis. This testing allows for the study of organ and tissue structure and function, as well as identifying abnormalities and diseases at a cellular level. Anatomic pathology testing encompasses a range of biopsy methods, such as fine needle aspiration biopsies, core needle biopsies, and surgical biopsies. The outcomes of these tests aid in the diagnosis of a variety of illnesses, including cancer, infectious diseases, and autoimmune disorders.

[491 Pages Updated Report 2023] Click Here to Access a Free Sample Report of the Global Anatomic Pathology Market- https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145

The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.

Key Market Players

The global anatomic pathology market for instruments and consumables is consolidated. The top five companies in this market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Beckton, Dickson and Company (US), and Abcam plc. (UK).

F. Hoffmann-La Roche AG (Switzerland) was the leading player in the anatomic pathology market in 2020. The company has a wide range of products in the consumables segment. Strong business operations across all key regions, coupled with a strong brand image, make the firm a leading player in this market. F. Hoffman-La Roche has adopted organic business strategies such as product launches in order to maintain its leading position in the anatomic pathology market. For instance, in 2020, the company received FDA approval for its CINtec PLUS Cytology test. Similarly, in 2018, the company received CE approval for its BenchMark ULTRA Plus staining system.

Danaher Corporation (US) was the second-leading player in the anatomic pathology market in 2020. The company has a broad product portfolio in the instruments segment. Moreover, Danaher also has a strong geographic presence with its direct distribution channels across the globe. The impressive product portfolio of the firm is complemented by its client support services. Over the years, Danaher has maintained its leading position in the market through continuous innovation and the launch of advanced products. For example, in 2018, Danaher launched various clinical microtomes, such as the HistoCore BIOCUT, HistoCore MULTICUT, and HistoCoreAUTOCUT clinical microtomes.

Anatomic Pathology Market: Regional Landscape

Presence of major key players in North America region is dominating the market growth.

The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

Browse Full Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html

Recent Developments in the Global Anatomic Pathology Market

  • Hologic received premarket approval (PMA) from the FDA for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications.
  • PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business to strengthen its position in the diagnostics segment.

What are the goals of the report?

  • The projected market size of the Anatomic Pathology Market industry at the end of the forecast period is presented in this market report.
  • Analysis of past and present market size.
  • Chart shows annual growth rate (%) and compound annual growth rate (CAGR) for each forecast period based on various indicators.
  • The Research includes market overview, geographic scope, segmentation and financial performance of key competitors.
  • The research assesses the current status and future growth opportunities of the industry in North America, Asia Pacific, Europe, Latin America, Middle East and Africa.

For More Information or Query or Customization before buying, Visit at @  https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=137323145

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html